Meeting
2022 ASCO Annual Meeting
Robust artificial intelligence-powered imaging biomarker based on mammography for risk prediction of breast cancer.
Authors
Eun Kyung Park
Lunit Inc., Seoul, South Korea
Eun Kyung Park , Hyeonsoo Lee , Minjeong Kim , Ki Hwan Kim , Hyeonseob Nam , Yoosoo Chang , Seungho Ryu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10533)
DOI
10.1200/JCO.2022.40.16_suppl.10533
Abstract #
10533
Poster Bd #
409
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Image-only deep learning risk model performance in patients with known germline mutations.
First Author: Faezeh Sodagari
Poster
2020 ASCO Virtual Scientific Program
ECOG-ACRIN tomosynthesis mammographic imaging screening trial (EA1151).
First Author: Etta Pisano
Poster
2015 Breast Cancer Symposium
A novel breast cancer screening platform: An epitope-based biomarker coupled to electrochemical sensor.
First Author: Yara Cristina Paiva Maia
Poster
2013 Breast Cancer Symposium
Screening in the high-risk populations: Stage of breast cancer when detected by combination imaging with MRI and mammogram.
First Author: Kendall W. Carpenter